Il glucagone spray nasale nel trattamento dell’ipoglicemia severa-Reference-Cited by-同舟云学术

Il glucagone spray nasale nel trattamento dell’ipoglicemia severa

Published:2022-05-25 Issue:3 Volume:23 Page:317-319
ISSN:1590-170X
Container-title:L'Endocrinologo
language:it
Short-container-title:L'Endocrinologo

Author:

Giandalia Annalisa,Alessi Eugenio

Publisher

Springer Science and Business Media LLC

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

https://link.springer.com/content/pdf/10.1007/s40619-022-01072-x.pdf

Reference8 articles.

1. Elliott L, Fidler C, Ditchfield A, Stissing T (2016) Hypoglycemia event rates: a comparison between real-world data and randomized controlled trial populations in insulin-treated diabetes. Diabetes Ther 7(1):45–60

2. Giorda CB, Ozzello A, Gentile S et al. on behalf of the HYPOS-1 Study Group (2014) Incidence and correlates of hypoglycemia in type 2 diabetes. The Hypos-1 study. J Diabetes Metab 5:344

3. Agiostratidou G, Anhalt H, Ball D et al. (2017) Standardizing clinically meaningful outcome measures beyond HbA1c for type 1 diabetes: a consensus report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, the Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange. Diabetes Care 40(12):1622–1630

4. Pontiroli AE, Alberetto M, Pozza G (1985) Metabolic effects of intranasally administered glucagon: comparison with intramuscular and intravenous injection. Acta Diabetol Lat 22:103–110

5. Rickels MR, Ruedy KJ, Foster NC et al. (2016) Intranasal glucagon for treatment of insulin-induced hypoglycemia in adults with type 1 diabetes: a randomized crossover noninferiority study. Diabetes Care 39:264–270